Gensight Biologics Confirms Sustained Efficacy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

GenSight Biologics Confirms Sustained Efficacy and Safety of Bilateral LUMEVOQ® Injections at 2-Year Follow-Up of REFLECT Phase III Trial

PARIS (BUSINESS WIRE) Dec 14, 2021

France generalUnited statesUnited kingdomMagali taielGensight biologics euronextGensight biologicsBernard gillyEuropean unionEuropean medicines agencyGensight biologics confirms sustained efficacyYear follow upCorrected visual acuityBusiness wireSight biologicsSpecial protocol assessmentLeber hereditary optic neuropathy

GenSight Biologics Confirms Sustained Efficacy and Safety of Bilateral LUMEVOQ® Injections at 2-Year Follow-Up of REFLECT Phase III Trial

GenSight Biologics Confirms Sustained Efficacy and Safety of Bilateral LUMEVOQ® Injections at 2-Year Follow-Up of REFLECT Phase III Trial
kxly.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kxly.com Daily Mail and Mail on Sunday newspapers.

France generalUnited statesUnited kingdomMagali taielJames palmerGensight biologics euronextGuillaume van renterghemJeanene timberlakeGensight biologicsBernard gillyThomas gidoinEuropean unionEuropean medicines agencyGensight biologics confirms sustained efficacyYear follow upCorrected visual acuity